STOCKS

RECOMMENDED BROKERS  
f
Comments Rating 4.7 (377 reviews)
f
Comments Rating 4.68 (374 reviews)
f
Comments Rating 4.7 (371 reviews)
Stocks, Stocks

Illumina stocks creep 17% lower on Q2 bleak results

On Friday’s pre-market session, shares of Illumina Inc. tanked after issuing downbeat earnings results and a bleak outlook. The American gene-sequencing company plummeted 16.91% or 38.45 points to $188.99 per

Sending
User Review
0 (0 votes)